Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-18

Clinical Trial Update: Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous serum eye drops as tears for recalcitrant dry eye associated with xerophthalmia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous serum eye drops (autologous serum)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Xerophthalmia | Phase 1 | Status: COMPLETED